摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-2-chloro-N'-(2-hydroxybenzylidene)benzohydrazide | 82859-77-6

中文名称
——
中文别名
——
英文名称
(E)-2-chloro-N'-(2-hydroxybenzylidene)benzohydrazide
英文别名
(E)-salicylaldehyde 2-chlorobenzoyl;H2LASSBio-466;2-chloro-benzoic acid salicylidenehydrazide;2-Chlor-benzoesaeure-salicylidenhydrazid;2-chloro-N-[(E)-(2-hydroxyphenyl)methyleneamino]benzamide;2-chloro-N-[(E)-(2-hydroxyphenyl)methylideneamino]benzamide
(E)-2-chloro-N'-(2-hydroxybenzylidene)benzohydrazide化学式
CAS
82859-77-6
化学式
C14H11ClN2O2
mdl
——
分子量
274.707
InChiKey
UUWKFQZODPGLRA-CXUHLZMHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    61.7
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (E)-2-chloro-N'-(2-hydroxybenzylidene)benzohydrazide巯基乙酸 为溶剂, 反应 10.0h, 以85%的产率得到2-Chloro-N-[2-(2-hydroxy-phenyl)-4-oxo-thiazolidin-3-yl]-benzamide
    参考文献:
    名称:
    Dutta; Goswami; Kataky, Journal of the Indian Chemical Society, 1990, vol. 67, # 4, p. 332 - 334
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    Modulation of estrogen-related receptors subtype selectivity: Conversion of an ERRβ/γ selective agonist to ERRα/β/γ pan agonists
    摘要:
    Estrogen Related Receptors (ERRs) are key regulators of energy homeostasis and play important role in the etiology of metabolic disorders, skeletal muscle related disorders, and neurodegenerative diseases. Among the three ERR isoforms, ERR alpha emerged as a potential drug target for metabolic and neurodegenerative diseases. Although ERR beta/gamma selective agonist chemical tools have been identified, there are no chemical tools that effectively target ERR alpha agonism. We successfully engineered high affinity ERR alpha agonism into a chemical scaffold that displays selective ERR beta/gamma agonist activity (GSK4716), providing novel ERR alpha/beta/gamma pan agonists that can be used as tools to probe the physiological roles of these nuclear receptors. We identified the structural requirements to enhance selectivity toward ERR alpha. Molecular modeling shows that our novel modulators have favorable binding modes in the LBP of ERR alpha and can induce conformational changes where Phe328 that originally occupies the pocket is dislocated to accommodate the ligands in a rather small cavity. The best agonists up-regulated the expression of target genes PGC-1 alpha and PGC-1 beta, which are necessary to achieve maximal mitochondrial biogenesis. Moreover, they increased the mRNA levels of PDK4, which play an important role in energy homeostasis.
    DOI:
    10.1016/j.bioorg.2020.104079
点击查看最新优质反应信息

文献信息

  • Analgesic and Anti-Inflammatory Activities of Salicylaldehyde 2-Chlorobenzoyl Hydrazone (H2LASSBio-466), Salicylaldehyde 4-Chlorobenzoyl Hydrazone (H2LASSBio-1064) and Their Zinc(II) Complexes
    作者:Walfrido Bispo Júnior、Magna S. Alexandre-Moreira、Marina A. Alves、Anayive Perez-Rebolledo、Gabrieli L. Parrilha、Eduardo E. Castellano、Oscar E. Piro、Eliezer J. Barreiro、Lídia Moreira Lima、Heloisa Beraldo
    DOI:10.3390/molecules16086902
    日期:——
    Salicylaldehyde 2-chlorobenzoyl hydrazone (H2LASSBio-466), salicylaldehyde 4-chlorobenzoyl hydrazone (H2LASSBio-1064) and their complexes [Zn(LASSBio-466)H2O]2 (1) and [Zn(HLASSBio-1064)Cl]2 (2) were evaluated in animal models of peripheral and central nociception, and acute inflammation. All studied compounds significantly inhibited acetic acid-induced writhing response. Upon coordination the anti-nociceptive activity was favored in the complex 1. H2LASSBio-466 inhibited only the first phase of the formalin test, while 1 was active in the second phase, like indomethacin, indicating its ability to inhibit nociception associated with the inflammatory response. Hence coordination to zinc(II) altered the pharmacological profile of H2LASSBio-466. H2LASSBio-1064 inhibited both phases but this effect was not improved by coordination. The studied compounds did not increase the latency of response in the hot plate model, indicating their lack of central anti-nociceptive activity. All compounds showed levels of inhibition of zymosan-induced peritonitis comparable or superior to indomethacin, indicating an expressive anti-inflammatory profile.
    水杨醛2-氯苯甲腇(H2LASSBio-466)、水杨醛4-氯苯甲腇(H2LASSBio-1064)及其配合物[Zn(LASSBio-466)H2O]2(1)和[Zn(HLASSBio-1064)Cl]2(2)在外周和中枢痛觉反应及急性炎症的动物模型中进行了评估。所有研究的化合物均显著抑制了醋酸诱导的扭体反应。在配位后,复合物1的抗痛觉活性得到了增强。H2LASSBio-466仅抑制了形式的测试中的第一阶段,而1在第二阶段中表现活跃,如吲哚美辛,表明其能够抑制与炎症反应相关的痛觉。因此,配位(II)改变了H2LASSBio-466的药理特征。H2LASSBio-1064抑制了两个阶段,但这种效果在配位后并没有改善。研究的化合物未增加热板模型中的反应潜伏期,表明其缺乏中枢抗痛觉活性。所有化合物对酵母菌诱导的腹膜炎的抑制平与吲哚美辛相当或更高,表明其具有显著的抗炎特性。
  • Sah, Recueil des Travaux Chimiques des Pays-Bas, 1940, vol. 59, p. 1029,1034
    作者:Sah
    DOI:——
    日期:——
  • Sun; Sah, Science Reports of National Tsing Hua University, Series A: Mathematical, Physical, and Engineering Sciences, 1934, vol. <A> 2, p. 359,361
    作者:Sun、Sah
    DOI:——
    日期:——
  • Poddar, S. N.; Samanta, G. C.; Mukherjee, G., Journal of the Indian Chemical Society, 1985, vol. 62, # 1, p. 7 - 10
    作者:Poddar, S. N.、Samanta, G. C.、Mukherjee, G.、Ghosh, S.
    DOI:——
    日期:——
  • DUTTA, M. M.;GOSWAMI, B. N.;KATAKY, J. C. S., J. INDIAN CHEM. SOC., 67,(1990) N, C. 332-334
    作者:DUTTA, M. M.、GOSWAMI, B. N.、KATAKY, J. C. S.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫